AI System to Help Lymphoma Patients Take Oral Medications
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests an artificial intelligence (AI) system designed to predict and help prevent medication non-compliance—meaning skipped or missed doses—in lymphoma patients taking oral (by-mouth) therapies. The goal is to catch problems early and support patients in taking their medications as prescribed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You are being treated for non-Hodgkin lymphoma (a type of blood cancer)
- You are receiving care at the Grand Hôpital de Charleroi in Belgium
- You are taking oral medication (pills or liquid) as part of your lymphoma treatment
- You are able to understand the study and give your permission to participate
- Your treatment must start on or after November 2025
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to look at tumor samples and MRI scans from people with advanced liver cancer to help choose the best treatment. It aims to make treatment more personalized and effective.
This trial tests if an AI-powered system can help monitor and manage side effects during chemotherapy for breast or colorectal cancer. If you are starting chemotherapy and can report your symptoms, this study may offer extra support.
This trial tests if an artificial intelligence (AI) program can help people with blood cancer learn about their condition and treatment. The goal is to see if AI-assisted education improves their understanding and care.
This trial tests an AI-assisted program that helps manage cancer care, especially for patients who also have other health conditions. If you join, the program may help coordinate your treatment and monitor your health, possibly leading to better outcomes.
This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.
This study tests whether an AI system can help doctors take notes during cancer consultations, so they can focus more on talking with you. If you join, your consultation will be audio-recorded, and the AI will help write the notes.
Hear when a new Care Coordination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.